New RSV vaccines approved thanks to Iowa trial work
The Pfizer Abrysvo and GSK Arexvy vaccines target pregnant women and adults 60 and older. UI Health Care helped test the Pfizer vaccine with about 150 Iowa participants. Trials showed high effectiveness and pave the way for broader protection against RSV's severe outcomes.
MENTIONED IN THIS ARTICLE
Iowa City
University of Iowa
UIHC
Christina Kopp
the Gazette
U.S
Centers For Disease
Kopp
United States
CDC
Food & Drug Administration
GSK
Pfizer
Patricia Winokur
UI Carver College of Medicine
Winokur
Uihc.org
RSV vaccines near for high risk groups and pregnant women
UIHC participates in RSV vaccine trials and advises vaccination for pregnant women to protect newborns. Trials show about 85 percent protection against serious RSV disease and immunity lasting about two years, with enrollment urged for transplant, dialysis, and cancer patients.
MENTIONED IN THIS ARTICLE
Winokur
UIHC
Also Mentioned on This Page
Christina
Kopp Uihc
Uf Health Care
Steve Varga
Varga
RSV
Vanessa. Miller
Thegazette
UI Rsv
Waypoint
Wonderland
Waypoint Wonderland
5Th St SE
Www
Waypointservices.org
Illins Mmunity Credit Union
The
Gazette
Collins Community Credit Union
Thegazette.com